Marianne Catherine Brown
Marianne Catherine Brown's purchase track record
Marianne Catherine Brown has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 3/28/2023 | SCHW | $267K | +3.1% | +1.6% | +7.6% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Charles Schwab Highlights AI Rules, Tax‑Aware Strategy and Q3 Outlook. Charles Schwab’s chief executive said AI‑driven trading agents will need clear regulatory guidelines, emphasizing the firm’s cautious stance on automated investing. The bank also announced a new tax‑aware investment strategy that has drawn significant assets from high‑net‑worth clients. UBS described the third‑quarter earnings report as “somewhat low quality,” though it noted continued strong organic growth. Additionally, the CEO mentioned expanding the firm’s prediction‑market offerings.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Akamai Expands Cloud AI Services, Boosting Customer Wins. Akamai has added several large cloud customers, signaling growth in its cloud services. The company is also expanding AI infrastructure and increasing global cloud adoption, which could strengthen its competitive position. These developments come as AI and enterprise SaaS workloads drive momentum for Akamai’s cloud business.
Transaction History
| NOC | ▲ Buy | Grant | 96 | $46K | 9/30/2026 | View on chart |
| NOC | ▲ Buy | Grant | 91 | $46K | 6/30/2026 | View on chart |
| SCHW | ▲ Buy | Grant | 1,602 | $0 | 5/26/2026 | View on chart |
| NOC | ▲ Buy | Grant | 349 | $193K | 5/20/2026 | View on chart |
| NOC | ▲ Buy | Grant | 68 | $46K | 3/31/2026 | View on chart |
| NOC | ▲ Buy | Grant | 81 | $46K | 12/31/2025 | View on chart |
| NOC | ▲ Buy | Grant | 76 | $46K | 9/30/2025 | View on chart |
| NOC | ▲ Buy | Grant | 93 | $46K | 6/30/2025 | View on chart |
| SCHW | ▲ Buy | Grant | 1,462 | $0 | 5/27/2025 | View on chart |
| NOC | ▲ Buy | Grant | 385 | $182K | 5/21/2025 | View on chart |
| NOC | ▲ Buy | Grant | 90 | $46K | 3/31/2025 | View on chart |
| NOC | ▲ Buy | Grant | 99 | $46K | 12/31/2024 | View on chart |
| NOC | ▲ Buy | Grant | 88 | $46K | 9/30/2024 | View on chart |
| NOC | ▲ Buy | Grant | 377 | $183K | 7/31/2024 | View on chart |
| NOC | ▲ Buy | Grant | 94 | $46K | 7/31/2024 | View on chart |
| SCHW | ▲ Buy | Grant | 1,809 | $0 | 5/28/2024 | View on chart |
| NOC | ▲ Buy | Grant | 94 | $45K | 3/31/2024 | View on chart |
| NOC | ▲ Buy | Grant | 96 | $45K | 12/31/2023 | View on chart |
| NOC | ▲ Buy | Grant | 102 | $45K | 9/30/2023 | View on chart |
| NOC | ▲ Buy | Grant | 99 | $45K | 6/30/2023 | View on chart |
| SCHW | ▲ Buy | Grant | 2,496 | $0 | 5/22/2023 | View on chart |
| AKAM | ▲ Buy | Option Exercise | 1,326 | $0 | 5/20/2023 | View on chart |
| NOC | ▲ Buy | Grant | 392 | $175K | 5/17/2023 | View on chart |
| NOC | ▲ Buy | Grant | 97 | $45K | 3/31/2023 | View on chart |
| SCHW | ▲ Buy | Open Market | 5,000 | $267K | 3/28/2023 | View on chart |
| NOC | ▲ Buy | Grant | 74 | $40K | 12/31/2022 | View on chart |
| NOC | ▲ Buy | Grant | 82 | $39K | 9/30/2022 | View on chart |
| NOC | ▲ Buy | Grant | 80 | $38K | 6/30/2022 | View on chart |
| AKAM | ▲ Buy | Option Exercise | 1,325 | $0 | 5/20/2022 | View on chart |
| SCHW | ▲ Buy | Grant | 2,054 | $0 | 5/19/2022 | View on chart |
| NOC | ▲ Buy | Grant | 385 | $175K | 5/18/2022 | View on chart |
| NOC | ▲ Buy | Grant | 84 | $38K | 3/31/2022 | View on chart |
| NOC | ▲ Buy | Grant | 97 | $38K | 12/31/2021 | View on chart |
| NOC | ▲ Buy | Grant | 104 | $37K | 9/30/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Northrop Grumman: Demand Intact Despite Softer Sentiment
Morgan Stanley notes that aerospace and defense demand remains steady as the company heads into earnings, even though market sentiment has eased. Northrop Grumman is expanding its supplier network through the ANH Structure and LITEF, and its precision weapons business could help sustain growth. The company’s valuation is below that of competitor Anduril, adding context to the sector’s competitive landscape.
Northrop Grumman: Demand Intact Despite Softer Sentiment. Morgan Stanley notes that aerospace and defense demand remains steady as the company heads into earnings, even though market sentiment has eased. Northrop Grumman is expanding its supplier network through the ANH Structure and LITEF, and its precision weapons business could help sustain growth. The company’s valuation is below that of competitor Anduril, adding context to the sector’s competitive landscape.